Company · King Of Prussia, Pennsylvania, United States
Aventis Behring Llc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 3
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| MONOCLATE-P - 200-350IU/VIAL | 02215144 | Cancelled Post Market | |
| MONOCLATE-P - 400-700IU/VIAL | 02215152 | Cancelled Post Market | |
| MONOCLATE-P - 800-1500IU/VIAL | 02215160 | Cancelled Post Market |
Notices of Compliance
Newest first.
- HUMATE-PDecember 6, 2004 · NOC 5990 · Supplement to a New Drug Submission (SNDS)
- MONOCLATE-PNovember 5, 2002 · NOC 193 · New Drug Submission (NDS)
- STREPTASEJune 4, 2002 · NOC 895 · New Drug Submission (NDS)
- MONONINEApril 4, 2001 · NOC 2138 · New Drug Submission (NDS)